HOME-Solid Tumors Clinical Trial
CSSIFM
CSSIFM logo
Meet the Team
clinical trials
Our medical staff consists of physicians, PAs, nurses, a dietitian and a research team
request an appointment
855-797-9277
our services
learn more
CSSIFM logo
Clinical Trials
Solid Tumors Clinical Trial
Our Clinical Trials
The Enrollment Process.
clinical trials
request an appointment
855-797-9277
our services
learn more
At CSSIFM we aim to conquer cancer with innovative and individualized therapies. Anne is a pancreatic cancer survivor and continues to teach us new dance moves at each visit. Did you know that studies show routine exercise can increase your body’s ability to fight cancer by inducing engagement of IL-15. At CSSIFM we believe it is important to never lose hope and to keep moving!
Solid Tumors-NEW-slider
Solid Tumors - AT1965-101 Clinical Trial
What to Expect
Primary purpose of this study:
This is a first-in-human, multicenter, open-label, dose escalation and dose expansion Phase 1/2 study to determine the MTD and/or the recommended Phase 2 dose (RP2D) and to characterize DLTs of AT-1965 as well as to investigate the safety, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of AT-1965 in patients with advanced, refractory or recurrent solid tumors (nonresectable and/or metastatic) including mTNBC.
Trial Name
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
Trial Information
Trial ID: COVID-4.019-LONG
Clinicaltrials.gov: NCT07123727
Acceptance Requirements
  1. Trial ID: ResQ117EX-ALC
  2. Clinicaltrials.gov: NCT06234098
  3. Eligibility Criteria
Apply
If you are interested in screening for this trial, please click the button below:
Learn more
Lung Cancer

Clinical Trials – Enrollment

Solid Tumors clinical trial.

Complete the form to connect with CSSIFM and start your clinical trial journey

Trial enrollment process

The Enrollment Process: What to Expect

    • Initial Online Questionnaire
      • Complete our brief online form so we can determine whether you meet the basic criteria for the study
    • Detailed Intake Form
      • If you appear to be potentially eligible, our team will send you a more detailed intake form to gather information about your diagnosis and medical history
    • Follow-up Call With Our Team
      • After reviewing your intake form, a member of our clinical team may contact you to verify your medical history, answer questions, and guide you on next steps
    • In-Person Screening Visit
      • If you remain eligible you will be scheduled for a screening visit. This includes a review by our providers and any required screening procedures such as laboratory work or medical tests to determine your eligibility
footer-final
Contact us
2040 East Mariposa Avenue
El Segundo, California 90245
Phone: 213-266-5600
Fax: 562-548-2304
Quick links
CSSIFM logo